163 related articles for article (PubMed ID: 29533008)
41. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.
Trassard M; Le Doussal V; Hacène K; Terrier P; Ranchère D; Guillou L; Fiche M; Collin F; Vilain MO; Bertrand G; Jacquemier J; Sastre-Garau X; Bui NB; Bonichon F; Coindre JM
J Clin Oncol; 2001 Jan; 19(2):525-34. PubMed ID: 11208847
[TBL] [Abstract][Full Text] [Related]
42. Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip.
Qi Y; Wang N; Pang LJ; Zou H; Hu JM; Zhao J; Zhang J; Liu CX; Zhang WJ; Yuan XL; Li F
BMC Med Genomics; 2015 Oct; 8():69. PubMed ID: 26503545
[TBL] [Abstract][Full Text] [Related]
43. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.
Spillane AJ; A'Hern R; Judson IR; Fisher C; Thomas JM
J Clin Oncol; 2000 Nov; 18(22):3794-803. PubMed ID: 11078492
[TBL] [Abstract][Full Text] [Related]
44. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
[TBL] [Abstract][Full Text] [Related]
45. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution.
Ferrari A; Gronchi A; Casanova M; Meazza C; Gandola L; Collini P; Lozza L; Bertulli R; Olmi P; Casali PG
Cancer; 2004 Aug; 101(3):627-34. PubMed ID: 15274077
[TBL] [Abstract][Full Text] [Related]
46. Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.
Tarkan Y; Erkan A; Selcuk ES; Mehmet K; Tugba KF; Ozlem US; Suleyman A; Tulay A; Bilge A; Ramazan Y; Yusuf G; Mevlude I; Umut D; Ilhan O; Abdurrahman I; Alper S; Dogan U; Necati A; Berna O; Gok DA; Ugur Y; Mahmut G
J Cancer Res Ther; 2014; 10(1):73-8. PubMed ID: 24762490
[TBL] [Abstract][Full Text] [Related]
47. Localized synovial sarcoma: A single institutional study of 191 patients with a minimum follow-up of 5 years for survivors.
Outani H; Nakamura T; Murata H; Stevenson J; Parry M; Gregory J; Tillman R; Jeys L; Abudu A
J Surg Oncol; 2019 Jun; 119(7):850-855. PubMed ID: 30786036
[TBL] [Abstract][Full Text] [Related]
48. Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study.
Ladenstein R; Treuner J; Koscielniak E; d'Oleire F; Keim M; Gadner H; Jürgens H; Niethammer D; Ritter J; Schmidt D
Cancer; 1993 Jun; 71(11):3647-55. PubMed ID: 8387883
[TBL] [Abstract][Full Text] [Related]
49. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
van Noesel MM; Orbach D; Brennan B; Kelsey A; Zanetti I; de Salvo GL; Gaze MN; Craigie RJ; McHugh K; Francotte N; Collini P; Bisogno G; Casanova M; Ferrari A
Pediatr Blood Cancer; 2019 Oct; 66(10):e27833. PubMed ID: 31241238
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Casanova M; Brennan B; Alaggio R; Kelsey A; Orbach D; van Noesel MM; Corradini N; Minard-Colin V; Zanetti I; Bisogno G; Gallego S; Merks JHM; De Salvo GL; Ferrari A
Eur J Cancer; 2020 Mar; 127():123-129. PubMed ID: 32007712
[TBL] [Abstract][Full Text] [Related]
52. Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.
Ferrari A; Trama A; De Paoli A; Bergeron C; Merks JHM; Jenney M; Orbach D; Chisholm JC; Gallego S; Glosli H; De Salvo GL; Botta L; Gatta G; Bisogno G;
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27882658
[TBL] [Abstract][Full Text] [Related]
53. Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization.
Nakagawa Y; Numoto K; Yoshida A; Kunisada T; Ohata H; Takeda K; Wai D; Poremba C; Ozaki T
J Cancer Res Clin Oncol; 2006 Jul; 132(7):444-50. PubMed ID: 16557383
[TBL] [Abstract][Full Text] [Related]
54. Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG).
Rogers TN; De Corti F; Burrieza GG; Guérin F; Terwisscha van Scheltinga S; Smeulders N; Craigie R; Jenney M; Kelsey A; Zanetti I; Coppadoro B; De Salvo GL; Bisogno G; Martelli H
Pediatr Blood Cancer; 2020 Sep; 67(9):e28479. PubMed ID: 32573979
[TBL] [Abstract][Full Text] [Related]
55. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature.
Andrassy RJ; Okcu MF; Despa S; Raney RB
J Am Coll Surg; 2001 Mar; 192(3):305-13. PubMed ID: 11245372
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
57. Multivariate analysis of prognostic factors in synovial sarcoma.
Koh KH; Cho EY; Kim DW; Seo SW
Orthopedics; 2009 Nov; 32(11):824. PubMed ID: 19902890
[TBL] [Abstract][Full Text] [Related]
58. Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions.
Al-Daraji W; Lasota J; Foss R; Miettinen M
Am J Surg Pathol; 2009 Oct; 33(10):1494-503. PubMed ID: 19623036
[TBL] [Abstract][Full Text] [Related]
59. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
[TBL] [Abstract][Full Text] [Related]
60. Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; Brennan B; Casanova M; Corradini N; Berlanga P; Schoot RA; Ramirez-Villar GL; Safwat A; Guillen Burrieza G; Dall'Igna P; Alaggio R; Lyngsie Hjalgrim L; Gatz SA; Orbach D; van Noesel MM
Cancer Manag Res; 2022; 14():2885-2902. PubMed ID: 36176694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
